For: | Ray G. Management of liver diseases: Current perspectives. World J Gastroenterol 2022; 28(40): 5818-5826 [PMID: 36353204 DOI: 10.3748/wjg.v28.i40.5818] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v28/i40/5818.htm |
Number | Citing Articles |
1 |
Mona M. AbouSamra. Liposomal nano-carriers mediated targeting of liver disorders: mechanisms and applications. Journal of Liposome Research 2024; : 1 doi: 10.1080/08982104.2024.2377085
|
2 |
Milena Georgieva, Charilaos Xenodochidis, Natalia Krasteva. Old age as a risk factor for liver diseases: Modern therapeutic approaches. Experimental Gerontology 2023; 184: 112334 doi: 10.1016/j.exger.2023.112334
|
3 |
Khaled A. Nematallah, Amgad Albohy, Noha Swilam. Phytotherapeutic approach to enhance the hepatoprotective activity of some edible plants: Molecular docking and nanoformulation. Journal of Functional Foods 2024; 122: 106471 doi: 10.1016/j.jff.2024.106471
|
4 |
Antoine Dumoutier, Aymeric Nicolas, Baptiste Bonnet, Yann Touchefeu, Jeremy Meyer, Frederic Douane, Eric Frampas, Lambros Tselikas, Arthur David. Percutaneous thermal ablation in hepatocellular carcinoma patients with and without TIPS. Abdominal Radiology 2024; doi: 10.1007/s00261-024-04655-4
|
5 |
F. V. Hladkykh, I. V. Bielochkina, I. V. Koshurba, M. O. Chyzh. Modern hepatoprotection: a narrative review of existing approaches and prospects for the use of biotechnological drugs. Modern medical technology 2023; (3): 58 doi: 10.34287/MMT.3(58).2023.9
|
6 |
Darya Pon`kina, Sergey Kuranov, Mikhail Khvostov, Nataliya Zhukova, Yulia Meshkova, Mariya Marenina, Olga Luzina, Tatyana Tolstikova, Nariman Salakhutdinov. Hepatoprotective Effect of a New FFAR1 Agonist—N-Alkylated Isobornylamine. Molecules 2023; 28(1): 396 doi: 10.3390/molecules28010396
|
7 |
Kshama Gupta, Prasad Mamidi. Ayurvedic management of chronic liver disease with portal hypertension and hepatic encephalopathy - A case report. International Journal of Complementary & Alternative Medicine 2023; 16(5): 240 doi: 10.15406/ijcam.2023.16.00659
|
8 |
Daisuke Usuda, Yuki Kaneoka, Rikuo Ono, Masashi Kato, Yuto Sugawara, Runa Shimizu, Tomotari Inami, Eri Nakajima, Shiho Tsuge, Riki Sakurai, Kenji Kawai, Shun Matsubara, Risa Tanaka, Makoto Suzuki, Shintaro Shimozawa, Yuta Hotchi, Ippei Osugi, Risa Katou, Sakurako Ito, Kentaro Mishima, Akihiko Kondo, Keiko Mizuno, Hiroki Takami, Takayuki Komatsu, Tomohisa Nomura, Manabu Sugita. Current perspectives of viral hepatitis. World Journal of Gastroenterology 2024; 30(18): 2402-2417 doi: 10.3748/wjg.v30.i18.2402
|
9 |
Feifei Lu, Yao Meng, Xiaoting Song, Xiaotong Li, Zhuang Liu, Chunru Gu, Xiaojie Zheng, Yi Jing, Wei Cai, Kanokwan Pinyopornpanish, Andrea Mancuso, Fernando Gomes Romeiro, Nahum Méndez-Sánchez, Xingshun Qi. Artificial Intelligence in Liver Diseases: Recent Advances. Advances in Therapy 2024; 41(3): 967 doi: 10.1007/s12325-024-02781-5
|
10 |
Anton Volniansky, Thierry L. Lefebvre, Merve Kulbay, Boyan Fan, Emre Aslan, Kim-Nhien Vu, Emmanuel Montagnon, Bich Ngoc Nguyen, Giada Sebastiani, Jeanne-Marie Giard, Marie-Pierre Sylvestre, Guillaume Gilbert, Guy Cloutier, An Tang. Inter-visit and inter-reader reproducibility of multi-parametric diffusion-weighted MR imaging in longitudinally imaged patients with metabolic dysfunction-associated fatty liver disease and healthy volunteers.. Magnetic Resonance Imaging 2024; 113: 110223 doi: 10.1016/j.mri.2024.110223
|
11 |
Li-jiao Sun, Xin Chen, Sai Zhu, Jin-jin Xu, Xiao-feng Li, Shao-xi Diao, Ying-li Yang, Jin-yu Liu, Jia-nan Wang, Ying-yin Sun, Cheng Huang, Xiao-ming Meng, Hua Wang, Xiong-wen Lv, Jun Li. Hesperetin derivative 2a inhibits lipopolysaccharide-induced acute liver injury in mice via downregulation of circDcbld2. Acta Pharmacologica Sinica 2024; 45(2): 354 doi: 10.1038/s41401-023-01171-x
|
12 |
Yu Jia, Yuyi Zhang, Shirui Chen, Zehua Jia, Tongdi Fang, Jiayi Zhang, Zhiyong Guo. Avatrombopag Elevates Platelet Counts and Reduces Platelet Transfusions in Patients With Chronic Liver Diseases During the Perioperative Period of Liver Transplantation. Organ Medicine 2024; 1(1): 38 doi: 10.1002/orm2.10
|
13 |
Valentin Blank, Thomas Karlas, Ulf Anderegg, Johannes Wiegand, Josi Arnold, Linnaeus Bundalian, Gabriela‐Diana Le Duc, Christiane Körner, Thomas Ebert, Anja Saalbach. Thy‐1 restricts steatosis and liver fibrosis in steatotic liver disease. Liver International 2024; 44(8): 2075 doi: 10.1111/liv.15956
|
14 |
Agata Michalak, Tomasz Lach, Karolina Szczygieł, Halina Cichoż-Lach. COVID-19, Possible Hepatic Pathways and Alcohol Abuse—What Do We Know up to 2023?. International Journal of Molecular Sciences 2024; 25(4): 2212 doi: 10.3390/ijms25042212
|
15 |
Jie Huang, Ding-Wei Xu, Ao Li. Can laparoscopic splenectomy and azygoportal disconnection be safely performed in patients presenting with cirrhosis, hypersplenism and gastroesophageal variceal bleeding? How to do it, tips and tricks (with videos). Current Problems in Surgery 2024; 61(7): 101501 doi: 10.1016/j.cpsurg.2024.101501
|